At a Glance
| MDAI | 5-MeO-MiPT | |
|---|---|---|
| Class | Entactogen | Psychedelic, Entactogen |
| Common Dose (oral) | 100–175 mg | 7–15 mg |
| Total Duration | 2.8–4.2 hrs | 2.8–4.7 hrs |
| Routes | oral | oralsmoked |
MDAI, a Entactogen, and 5-MeO-MiPT, a Psychedelic, Entactogen, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. MDAI is classified as a Entactogen while 5-MeO-MiPT is a Psychedelic, Entactogen, meaning they approach altered states through different pharmacological mechanisms. They share 17 documented effects in common, with 23 effects unique to MDAI and 27 unique to 5-MeO-MiPT. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| MDAI | 5-MeO-MiPT | |
|---|---|---|
| Class | Entactogen | Psychedelic, Entactogen |
| Common Dose (oral) | 100–175 mg | 7–15 mg |
| Total Duration | 2.8–4.2 hrs | 2.8–4.7 hrs |
| Routes | oral | oralsmoked |
| Effects | 40 documented | 44 documented |
| Level | MDAI | 5-MeO-MiPT |
|---|---|---|
| Threshold | 40 mg | 3 mg |
| Light | 40–100 mg | 3–7 mg |
| Common | 100–175 mg | 7–15 mg |
| Strong | 175–300 mg | 15–20 mg |
| Heavy | 300 mg | 20 mg |
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 5–10 mg |
| Common | 10–15 mg |
| Strong | 15–20 mg |
| Heavy | 20 mg |
MDAI
5-MeO-MiPT
No direct interaction data available between these substances. This does not mean the combination is safe.